AFT reports 32% rise in gross profit

The pharmaceutical company has also seen a 16% growth in revenue, as it launches Maxigesic across several countries AFT Pharmaceuticals has announced its full-year audited financial results for the year ending 31 March 2018 (FY2018). “The FY2018 results reflect the significant progress on development and commercialisation of our key innovative products in addition to expanding